hospitals

Beyond Senior Design: Bringing Hospital Communications into the Future

By: Eli Freund, Editorial Communications Manager, UConn School of Engineering

Hospitals are one of the busiest places that an individual can be in. Doctors and nurses are running around, often supervising many patients, and during hectic times caregivers are confronted with the task of prioritizing patient’s needs, which is a very complex process. But two former UConn Engineering students are looking to streamline patient-caregiver interactions through a device called YouCOMM.

The device, which is being developed by two recent engineering alumni, Tom Cotton (B.S. BME ’17, M.S. BME ’18) and Daniel Yasoshima (B.S. BME ’17, M.S. BME ’18), is a tablet-based platform with an interface allowing the patient to choose their problem or need from a list, or write a custom message to the caregiver. Once completed, that message is sent as a text message directly to the caregiver assigned to that patient.

Read more @ Engineering News

Vibrational Therapy to Change the 
Outlook for Cerebral Palsy Patients

By: Eli Freund, Editorial Communications Manager, UConn School of Engineering

This article is part of a multi-part series on engineering students, and their journey through senior design. Click here to read part 1 of this article series.

Entering the final stretch of their Senior Design journey, the biomedical engineering team of Brianna Perry, Morgan DaSilva, Brittany Morgan, and Katie Bradley are realizing the crushing realities of real-world results versus perfect-world expectations.

In a perfect world, the team of four would be running trials with their cerebral palsy rehabilitation device on multiple CP patients, and all their equipment would be running perfectly. Unfortunately, that isn’t the case, according to Perry:

“After a long process, the Institutional Review Board finally approved our human trials, allowing us to get some participants,” Perry said. “Unfortunately, due to time constraints, and our inability to compensate participants, we were only able to enroll one CP patient in our trials.”

Read more @ Engineering News